The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review
Open accessAbstract
Objective: To determine the effectiveness of anticholinergic drugs for the treatment of overactive bladder syndrome. Design: Systematic review of randomised controlled trials. Data sources: Published papers and abstracts. Study selection: Randomised controlled trials with anticholinergic drug treatment in one arm and placebo in another. Data extraction: Primary outcomes of interest were patient perceived cure or improvement in symptoms, differences in number of incontinent episodes and number of voids in 24 hours, and side effects. Secondary outcomes of interest were urodynamic measures of bladder function (volume at first contraction, maximum cystometric capacity, and residual volume) and adverse events. Data synthesis: 32 trials were included, totalling 6800 participants. Most trials were described as double blind but were variable in other aspects of quality. At the end of treatment, cure or improvement (relative risk 1.41, 95% confidence interval 1.29 to 1.54), differences in incontinent episodes in 24 hours (estimated mean difference 0.6, 0.4 to 0.8), number of voids in 24 hours (0.6, 0.4 to 0.8), maximum cystometric capacity (54 ml, 43 ml to 66 ml), and volume at first contraction (52 ml, 37 ml to 67 ml), were significantly in favour of anticholinergics (P<0.0001 for all). Anticholinergics were associated with significantly higher residual volumes (4 ml, 1 ml to 7 ml; P=0.02) and an increased rate of dry mouth (relative risk 2.56, 2.24 to 2.92; P<0.0001). Sensitivity analysis, although affected by small numbers of studies, showed little likelihood of an effect of age, sex, diagnosis, or choice of drug. Conclusions: Although statistically significant, the differences between anticholinergic drugs and placebo were small, apart from the increased rate of dry mouth in patients receiving active treatment. For many of the outcomes studied, the observed difference between anticholinergics and placebo may be of questionable clinical significance. None of these studies provided data on long term outcome. What is already known on this topic: Anticholinergics are the first line medical treatment for overactive bladder The effectiveness of these drugs is unclear What this study adds: Anticholinergics produce significant improvements in overactive bladder symptoms compared with placebo The benefits are, however, of limited clinical significance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Milsom, I., Abrams, P., Cardozo, L., Roberts, R. G., Thüroff, J., & Wein, A. J. (2001) · BJU International · doi:10.1046/j.1464-410x.2001.02228.x · Cited by 1,752
Understanding controlled trials: What are pragmatic trials?
Roland, M., & Torgerson, D. J. (1998) · BMJ · doi:10.1136/bmj.316.7127.285 · Cited by 702
Prevalence of urinary incontinence and associated risk factors in postmenopausal women
Brown, J. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00263-x · Cited by 410
Bladder training for urinary incontinence in adults
Wallace, S. A., Roe, B., Williams, K., & Palmer, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001308.pub2 · Cited by 287
Urinary, faecal and sexual dysfunction in patients with multiple sclerosis
Hennessey, A., Robertson, N. P., Swingler, R., & Compston, D. A. S. (1999) · Journal of Neurology · doi:10.1007/s004150050508 · Cited by 224
The prevalence and bothersomeness of lower urinary tract symptoms in women 40–60 years of age
ALLING MØLLER, L., LOSE, G., & JØRGENSEN, T. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079004298.x · Cited by 210
Yaphe, J., Edman, R., Knishkowy, B., & Herman, J. (2001) · Family Practice · doi:10.1093/fampra/18.6.565 · Cited by 159
The patient with an overactive bladder—Symptoms and quality-of-life issues
Jackson, S. (1997) · Urology · doi:10.1016/s0090-4295(97)00580-3 · Cited by 149
Beyond conflict of interestA common problemBuilding a convincing caseWhat should the BMJ be doing?
Smith, R. W. (1998) · BMJ · doi:10.1136/bmj.317.7154.291 · Cited by 145
Cited by
Chapple, C. R., Khullar, V., Gabriel, Z., Muston, D., Bitoun, C. E., & Weinstein, D. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.047 · Cited by 769
Cruz, F., Herschorn, S., Aliotta, P., Brin, M., Thompson, C., Lam, W., Daniell, G., Heesakkers, J., & Haag-Molkenteller, C. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.002 · Cited by 473
EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence
Lucas, M. G., Bosch, R. J. L., Burkhard, F. C., Cruz, F., Madden, T. B., Nambiar, A. K., Neisius, A., de Ridder, D. J. M. K., Tubaro, A., Turner, W. H., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.08.047 · Cited by 422
Antimuscarinics for treatment of overactive bladder
Andersson, K.-E. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00622-7 · Cited by 414
Management of Overactive Bladder
Ouslander, J. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032662 · Cited by 411
Metadata
- Authors
- Herbison, P., Hay-Smith, J., Ellis, G., & Moore, K.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2003-04-19
- Volume
- 326
- Issue
- 7394
- Pages
- 841.1
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2119809361
- Cited by
- 337
- References
- 13
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. https://app.cochat.ai/papers/10.1136/bmj.326.7394.841
- The paper
- Herbison, P., Hay-Smith, J., Ellis, G., & Moore, K. (2003). Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. https://doi.org/10.1136/bmj.326.7394.841
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.